Abela program (Nanologica/Alcyone)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAbela program (Nanologica/Alcyone)
Drug Alias Namenanoporous silica-encapsulated trophic factors + embryonic stem cell-derived cells (Nanologica/Alcyone)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Embryonic stem cells therapy
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSweden
CombinationsYes
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNanologica AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlcyone Lifesciences IncNanologica AB
Active IndicationsN/A
Inactive IndicationsAmyotrophic Lateral Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A